Finanzwire Finanzwire
Basculer en Français
10844 Companies
235476 Keywords
164409 Articles
126177 Press releases
Headlines Articles Press releases MAbxience Remove
  1. Home
  2. Companies
  3. MAbxience
Finanzwire
Basculer en Français
Headlines Articles Press releases

News

  • BRIEF

    published on 12/22/2025 at 22:10, 7 months 26 days ago

    FDA Approves mAbxience and Amneal's Denosumab Biosimilars

    FDA Approval Amneal Pharmaceuticals Denosumab Biosimilars MAbxience Affordable Biologics
  • PRESS RELEASE

    published on 12/22/2025 at 22:05, 7 months 26 days ago

    mAbxience and Amneal Announces FDA Approval of Denosumab Biosimilars Referencing Prolia® and XGEVA®

    mAbxience and Amneal announced FDA approval of denosumab biosimilars referencing Prolia and XGEVA, expanding affordable biologic access in the US
    FDA Approval Denosumab Biosimilars MAbxience Amneal Prolia XGEVA
    Logo of MAbxience
  • BRIEF

    published on 12/04/2025 at 09:10, 8 months 13 days ago

    MAbxience and HP Collaborate on AI in Biomanufacturing

    Artificial Intelligence Biosimilars Biomanufacturing MAbxience HP Inc.
  • PRESS RELEASE

    published on 12/04/2025 at 09:05, 8 months 13 days ago

    mAbxience and HP drive the use of artificial intelligence in biomanufacturing and biosimilar development

    mAbxience and HP collaborate on AI solution to optimize biomanufacturing and biosimilar development, enhancing predictability and efficiency. Project aims to improve patient access to biologic therapies
    AI Solution Biosimilar Development Biomanufacturing MAbxience HP
    Logo of MAbxience
Accesswire
  • Published on 08/17/2026 at 22:30, 1 hour 33 minutes ago

    Matador Technologies Amends Convertible Note Facility to Expand At the Market Capacity and Commit a Fixed Share of Proceeds to Bitcoin

  • Published on 08/17/2026 at 21:00, 3 hours 3 minutes ago

    Taranis Announces New Critical Minerals By-Product Findings at the Thor and Ajax Mines

  • Published on 08/17/2026 at 15:00, 9 hours 3 minutes ago

    Norsemont Appoints Ariel Tepperman to Its Board

  • Published on 08/17/2026 at 14:30, 9 hours 33 minutes ago

    Alset AI Completes Sale of 9.9% Interest in Lyken AI Computing to FingerMotion

  • Published on 08/17/2026 at 14:00, 10 hours 3 minutes ago

    FaZe Esports, a GameSquare Company, Wins Rainbow Six Championship at 2026 Esports World Cup

View all ACCESSWIRE
EQS Group
  • Published on 08/17/2026 at 22:30, 1 hour 33 minutes ago

    PLAY HAS ARRIVED IN GERMANY

  • Published on 08/17/2026 at 18:50, 5 hours 13 minutes ago

    Holding(s) in Company

  • Published on 08/17/2026 at 17:50, 6 hours 13 minutes ago

    EvoNext Holdings SA confirms advanced discussions on a reverse merger with Ascend Sport Technology AG

  • Published on 08/17/2026 at 17:47, 6 hours 16 minutes ago

    Key Figures 15.08.2026

  • Published on 08/17/2026 at 17:45, 6 hours 18 minutes ago

    Press release: Information on Leonteq's shareholder base

View all EQS
Les Echos
  • Published on 08/17/2026 at 19:45, 4 hours 18 minutes ago

    Aéroports de Paris S.A - July 2026 traffic figures

  • Published on 08/17/2026 at 17:45, 6 hours 18 minutes ago

    Weekly share buyback

  • Published on 08/17/2026 at 08:33, 15 hours 30 minutes ago

    Covivio - Information on Treasury shares transactions between August 10th, 2026 and August 11th, 2026

  • Published on 08/17/2026 at 07:30, 16 hours 33 minutes ago

    Disclosure of transactions in own shares from August 10 to August 14, 2026

  • Published on 08/10/2026 at 18:00, 7 days 6 hours ago

    AXA: Information relating to the number of voting rights and shares making up the share capital on 31/07/2026

View all LES ECHOS COMFI WIRE

With finanzwire.com, you can follow all the latest financial news in real time from the best sources for companies listed on the Paris, Brussels, Amsterdam, Lisbon, Frankfurt and New York stock exchanges. You'll have access to summary articles written by us and press releases published by the companies themselves.

Finanzwire

87, rue Ordener - 75018 Paris

Contact us

+33 1 42 23 83 61

© 2026 Finanzwire

Contact Authors Cookies policy Terms and conditions Privacy policy